Securities ▲▼ | Shares | Value ($K) | |||||
|---|---|---|---|---|---|---|---|
Q3 2024 ▲▼ | Q4 2024 ▲▼ | Change ▲▼ | Q3 2024 ▲▼ | Q4 2024 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Entrada Therapeutics, Inc. | 4,425,784 | 4,381,062 | -44,722 | 70,724 | 75,749 | 60.89% | +5,025 |
| Adaptimmune Therapeutics plc | 5,555,461 | 5,555,461 | 0 | 5,278 | 2,994 | 2.41% | -2,283 |
| Werewolf Therapeutics, Inc. | 4,284,172 | 4,284,172 | 0 | 9,082 | 6,341 | 5.10% | -2,742 |
| Repare Therapeutics, Inc. | 2,242,636 | 1,683,707 | -558,929 | 7,715 | 2,206 | 1.77% | -5,509 |
| iTeos Therapeutics, Inc. | 2,738,785 | 2,738,785 | 0 | 27,963 | 21,034 | 16.91% | -6,929 |
| Dyne Therapeutics, Inc.(DYN) | 682,376 | 682,376 | 0 | 24,511 | 16,077 | 12.92% | -8,434 |